Viome Life Sciences raises $67M Series C to expand at-home gut, immune and cancer screening tests

Bellevue-based Viome Life Sciences raised over $67 million in Series C funding to expand its at-home health screening test business, bringing total capital raised to more than $150 million. Founder and CEO Naveen Jain said the company plans to grow headcount from about 150 to ~200 and will hire more scientists, researchers, and engineers while keeping lab and supplement manufacturing automated.

NNaveen Jain VViome WWestRiver Group